by Viara Staneva | Apr 10, 2020 | news
Pharma marketing, like the rest of the ad industry, is in a state of flux brought on by the COVID-19 pandemic. Concerns and debates are swirling around whether drug ads should scale back, if drugmakers should change messaging to be more serious or if they should delay...
by Viara Staneva | Mar 14, 2020 | news
The novel coronavirus has hit home at Biogen, where three executives who traveled to a headquarters management meeting have tested positive for the illness. At last week’s meeting, a “number of attendees reported varying degrees of flu-like symptoms,” the...
by Viara Staneva | Mar 4, 2020 | news
Around 10 PM ET last night, the FDA said that it is aware of a drug shortage related to an active pharmaceutical ingredient (API) manufacturer affected by the coronavirus, but the agency stopped short of revealing what drug it is. “The shortage is due to an issue with...
by Viara Staneva | Feb 28, 2020 | news
Direct-to-consumer drug ads tend to strike a dissonant chord. However, fan and foe can count on one thing: Prescription DTC advertising is here to stay. The evidence? Surviving more than 20 years of numerous legal, regulatory and perception challenges on its way to...
by Viara Staneva | Feb 24, 2020 | news
After years of opioid litigation and a multibillion-dollar settlement offer from the nation’s top drug distributors, nearly two dozen U.S. states have rejected their proposal, The Wall Street Journal reports. Twenty-one state attorneys general sent a letter to...
